Effects of Bezafibrate Treatment in a Patient and a Carrier With Mutations in the PNPLA2 Gene, Causing Neutral Lipid Storage Disease With Myopathy
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Item does not contain fulltext
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase
Haemmerle, G., Lass, A., Zimmermann, R., Gorkiewicz, G., Meyer, C., Rozman, J., Heldmaier, G., Maier, R., Theussl, C., Eder, S., et al. (2006) · Science · doi:10.1126/science.1123965 · Cited by 1,375 · cited 1×
“Just like NLSDM patients, ATGLdeficient mice are also characterized by excessive lipid storage in skeletal muscle, liver, and heart, and they develop cardiomyopathy at a young age, resulting in premature death.(3) Interestingly, we reported recently that a lack of ATGL resulted in a diminished cardiac peroxisome proli…”
BackgroundSelf-citation
Cited by
Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence
Cheng, H. S., Tan, W. R., Low, Z. S., Marvalim, C., Lee, J. Y. H., & Tan, N. S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205055 · Cited by 264
Targeting fatty acid metabolism to improve glucose metabolism
Stinkens, R., Goossens, G. H., Jocken, J. W. E., & Blaak, E. E. (2015) · Obesity Reviews · doi:10.1111/obr.12298 · Cited by 183
Phua, W. W. T., Wong, M. X. Y., Liao, Z., & Tan, N. S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051425 · Cited by 72
“However, treatment with a PPARα agonist was less successful in humans than in rodents [69].”
BackgroundBezafibrate improves insulin sensitivity and metabolic flexibility in STZ-induced diabetic mice
Franko, A., Huypens, P., Neschen, S., Irmler, M., Rozman, J., Rathkolb, B., Neff, F., Prehn, C., Dubois, G., Baumann, M., et al. (2016) · Diabetes · doi:10.2337/db15-1670 · Cited by 42
“BEZ-treated patients carrying the PNPLA2 mutation also show ameliorated metabolic flexibility in parallel with improved mitochondrial function and insulin sensitivity (54), suggesting that enhanced metabolic flexibility could have clinical relevance in BEZ therapies.”
Background
Metadata
- Authors
- van de Weijer, T., Havekes, B., Bilet, L., Hoeks, J., Sparks, L., Bosma, M., Paglialunga, S., Jorgensen, J., Janssen, M. C. H., Schaart, G., Sauerwein, H., Smeets, J. L., Wildberger, J., Zechner, R., Schrauwen-Hinderling, V. B., Hesselink, M. K. C., & Schrauwen, P.
- Venue
- Circulation Research
- Published
- 2013-03
- Volume
- 112
- Issue
- 5
- Pages
- e51-4
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2010426240
- Cited by
- 46
- References
- 1
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of Bezafibrate Treatment in a Patient and a Carrier With Mutations in the PNPLA2 Gene, Causing Neutral Lipid Storage Disease With Myopathy. https://app.cochat.ai/papers/10.1161/circresaha.113.300944
- The paper
- van de Weijer, T., Havekes, B., Bilet, L., Hoeks, J., Sparks, L., Bosma, M., Paglialunga, S., Jorgensen, J., Janssen, M. C. H., Schaart, G., Sauerwein, H., Smeets, J. L., Wildberger, J., Zechner, R., Schrauwen-Hinderling, V. B., Hesselink, M. K. C., & Schrauwen, P. (2013). Effects of Bezafibrate Treatment in a Patient and a Carrier With Mutations in the PNPLA2 Gene, Causing Neutral Lipid Storage Disease With Myopathy. Circulation Research. https://doi.org/10.1161/circresaha.113.300944
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.